Yijing Shen

5.8k total citations · 1 hit paper
32 papers, 4.1k citations indexed

About

Yijing Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yijing Shen has authored 32 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Yijing Shen's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Yijing Shen is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Yijing Shen collaborates with scholars based in China, United States and Japan. Yijing Shen's co-authors include Anthony Lee, Gene Grant Finley, Mark A. Socinski, Marcin Kowanetz, Ariel López-Chávez, Denis Moro‐Sibilot, Shelley Coleman, Fabrice Barlési, Daniil Stroyakovskiy and Francesco Orlandi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Yijing Shen

31 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC

2018 2.6k citations Yijing Shen et al. profile →

Peers

Countries citing papers authored by Yijing Shen

Since Specialization

Citations

This map shows the geographic impact of Yijing Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yijing Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yijing Shen more than expected).

Fields of papers citing papers by Yijing Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yijing Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yijing Shen. The network helps show where Yijing Shen may publish in the future.

Co-authorship network of co-authors of Yijing Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yijing Shen. A scholar is included among the top collaborators of Yijing Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yijing Shen. Yijing Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevention and control of myopia based on meridians and zang-fu organs theory for unblocking meridians and harmonizing zang-fu organs 2024 ·Theoretical and Natural Science ·Yi Zhao, Shichao Jiang, Yuxia Chen, Zhiwei Chen, Yijing Shen	1
2	NLRC4 methylation and its response to intravenous immunoglobulin therapy in Kawasaki disease: a case control study 2024 ·BMC Pediatrics ·(unknown), (unknown), (unknown), Yijing Shen, Haiyan Qiu, (unknown), Yuanling Chen, Xiaohong Cai, Junhua Wu, (unknown)	0
3	Effect of salt substitute and antihypertensive medications among high cardiovascular risk patients: A sub‐study of Salt Substitute and Stroke Study (SSaSS) 2024 ·Journal of Clinical Hypertension ·(unknown), Shuai Tang, (unknown), (unknown), (unknown), Hongmei Yang, Yijing Shen, Liping Huang, Maoyi Tian, Xiangxian Feng, Zhifang Li	3
4	A green and cost-effective zinc-biphenol hybrid flow battery with eutectic electrolyte 2024 ·Journal of Energy Storage ·(unknown), Yijing Shen, Jianyu Cao, Yong‐Miao Shen, Juan Xu	2
5	Plasma tRF-16-79MP9PD and tRF-28-OB1690PQR304 as potential biomarkers for 4- to 7-year-old children with obstructive sleep apnea-hypopnea syndrome 2023 ·Frontiers in Pediatrics ·Junhua Wu, (unknown), (unknown), Yijing Shen, Zhisen Shen, (unknown)	1
6	The potential of tRF-21-U0EZY9X1B plasmatic level as a biomarker of children with obstructive sleep apnea-hypopnea syndrome 2023 ·BMC Pediatrics ·(unknown), Qiang Fu, (unknown), Yijing Shen, Junhua Wu, Haiyan Qiu	1
7	The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathway 2021 ·Stem Cell Research & Therapy ·Linwen Zhu, Zhe Li, Xiuchong Yu, Yao Ruan, Yijing Shen, Yongfu Shao, Xinjun Zhang, Guoliang Ye, Junming Guo	54
8	Correlation Analysis of Hemoglobin-to-Red Blood Cell Distribution Width Ratio and Frailty in Elderly Patients With Coronary Heart Disease 2021 ·Frontiers in Cardiovascular Medicine ·(unknown), Ting Zhou, (unknown), (unknown), Yijing Shen, Yu‐Hui Chen, Lei Tang, Qian Lin, (unknown), (unknown), Yongbing Liu	49
9	Research Trends and Hotspots on Montessori Intervention in Patients With Dementia From 2000 to 2021: A Bibliometric Analysis 2021 ·Frontiers in Psychiatry ·(unknown), (unknown), (unknown), (unknown), Yijing Shen, Yongbing Liu	13
10	Clinical diagnostic values of transfer RNA-derived fragment tRF-19-3L7L73JD and its effects on the growth of gastric cancer cells 2021 ·Journal of Cancer ·Yijing Shen, Yaoyao Xie, Xiuchong Yu, Shuangshuang Zhang, (unknown), Guoliang Ye, Junming Guo	38
11	Global profile of tRNA-derived small RNAs in gastric cancer patient plasma and identification of tRF-33-P4R8YP9LON4VDP as a new tumor suppressor 2021 ·International Journal of Medical Sciences ·Yijing Shen, Xiuchong Yu, Yao Ruan, Zhe Li, Yaoyao Xie, Zhilong Yan, Junming Guo	46
12	Relationship Between Medication Literacy and Frailty in Elderly Inpatients With Coronary Heart Disease: A Cross-Sectional Study in China 2021 ·Frontiers in Pharmacology ·(unknown), Ting Zhou, (unknown), (unknown), Yijing Shen, Yongbing Liu	10
13	Health literacy, social support, and care ability for caregivers of dementia patients: Structural equation modeling 2020 ·Geriatric Nursing ·Yongnan Li, (unknown), (unknown), Yijing Shen, Huiping Xue, Ping Hou, Yongbing Liu	41
14	tRNA-derived fragments and tRNA halves: The new players in cancers 2019 ·Cancer Letters ·Linwen Zhu, Jiaxin Ge, Tianwen Li, Yijing Shen, Junming Guo	163
15	Transfer RNA-derived fragments and tRNA halves: biogenesis, biological functions and their roles in diseases 2018 ·Journal of Molecular Medicine ·Yijing Shen, Xiuchong Yu, Linwen Zhu, Tianwen Li, Zhilong Yan, Junming Guo	190
16	A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study 2013 ·Lara D. Veeken ·Shintaro Hirata, Linda Dirven, Yijing Shen, Michael Centola, G. Cavet, Willem F. Lems, Yoshiya Tanaka, T. Huizinga, Cornelia F Allaart	70
17	Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis 2013 ·PLoS ONE ·Michael Centola, G. Cavet, Yijing Shen, Saroja Ramanujan, Nicholas Knowlton, Kathryn A. Swan, (unknown), Chris W. Sutton, Dustin R. Smith, Douglas J. Haney, David Chernoff, Lyndal K. Hesterberg, John P. Carulli, Peter C. Taylor, Nancy A. Shadick, Michael E. Weinblatt, Jeffrey R. Curtis	130
18	Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity 2012 ·Arthritis Care & Research ·Jeffrey R. Curtis, Annette H M van der Helm–van Mil, Rachel Knevel, T. Huizinga, Douglas J. Haney, Yijing Shen, Saroja Ramanujan, G. Cavet, Michael Centola, Lyndal K. Hesterberg, David Chernoff, (unknown), Nancy A. Shadick, Max Hamburger, Roy Fleischmann, Edward Keystone, Michael E. Weinblatt	138
19	Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study 2012 ·Annals of the Rheumatic Diseases ·Marije F. Bakker, G. Cavet, Johannes W. G. Jacobs, J. W. J. Bijlsma, Douglas J. Haney, Yijing Shen, Lyndal K. Hesterberg, Dustin R. Smith, Michael Centola, Joël A. G. van Roon, Floris P. J. G. Lafeber, Paco M J Welsing	92
20	Abstract B49: GRN1005 phase I studies: Final results. 2011 ·Molecular Cancer Therapeutics ·Patrick Y. Wen, Jan Drappatz, Andrew Brenner, Tom Mikkelsen, David Schiff, Steven S. Rosenfeld, Morris D. Groves, Yijing Shen, Xiaolin Wang, Mona Shing, Betty Lawrence, Jean‐Paul Castaigne, N. Gabrail, John Sarantopoulos, Razelle Kurzrock	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact